Aurealis Therapeutics
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $24M
Investors
- 6
About Aurealis Therapeutics
D. Thomas Wirth and Heinz List, Aurealis Therapeutics, formerly Aurealis Pharma operates as a Nordic cell and gene therapy platform company developing gene therapy drugs for chronic wounds and other inflammatory degenerative diseases. Aurealis Therapeutics provides AUP-16 for chronic wounds patients and is under phase-1 trial for diabetic foot ulcer (DFU) patients. The company offers AUP-55 and AUP-65 for ovarian cancer and another secondary peritoneal carcinomatosis and is under pre-clinical trials. In addition, the firm provides AUP-18 and AUP-20 for inflammation therapy for its patients.
Who invested in Aurealis Therapeutics
6 investors across 3 rounds
See all investors in Aurealis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aurealis Therapeutics
Who invested in Aurealis Therapeutics?
Aurealis Therapeutics has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aurealis Therapeutics raised?
Aurealis Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Aurealis Therapeutics last raise money?
Aurealis Therapeutics's most recent round on record is a Series A, in Mar 2023.
What does Aurealis Therapeutics do?
Aurealis Therapeutics is a biotechnology company.
Where is Aurealis Therapeutics headquartered?
Aurealis Therapeutics is headquartered in Zug, Switzerland.
Which VCs invest in companies like Aurealis Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Aurealis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aurealis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.